RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
MARCHETTI M
Collezione ASL Asti
Items : 68
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. in The Lancet. Haematology / Lancet Haematol. 2024 Feb;11(2):e147-e159. doi: 10.1016/S2352-3026(23)00342-3. Epub 2024 Jan 3.
2024
ASL Asti
Wolff D; Vrhovac R; Solano C; Schoemans H; Ruutu T; Patriarca F; Nagler A; Passweg J; Mohty M; Kröger N; Mielke S; Hazenberg MD; Giebel S; Greinix H; Bonifazi F; Duarte RF; Aljurf M; Arat M; Marchetti M; Penack O; Zeiser R; Sureda A; Peric Z;
2023
ASL Asti
Caocci G; Palandri F; Loscocco GG; Tieghi A; Patriarca A; Iurlo A; Abruzzese E; Rossi E; Baldi T; Fava C; Beggiato E; Tomasetti S; Marchetti M; Vanni D; Fozza C; Luppi M; La Nasa G; Fazi P; Vignetti M; Vannucchi AM; Efficace F;
Comparative Clinical Value of Pharmacologic Therapies for B-Cell Chronic Lymphocytic Leukemia: An Umbrella Analysis. in Journal of clinical medicine / J Clin Med. 2022 Mar 28;11(7):1868. doi: 10.3390/jcm11071868.
2022
AOU Alessandria
ASL Asti
Canicattì M; Bertassello C; Rivela P; Marchetti M;
Pharmacoeconomic considerations for acute myeloid leukemia pharmacotherapy. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2022 Feb;23(2):263-272. doi: 10.1080/14656566.2021.2014453. Epub 2021 Dec
2022
ASL Asti
AOU Alessandria
Marchetti M; Albertin L; Limberti G; Canicattì M;
2022
ASL Asti
Caocci G; Palandri F; Loscocco GG; Piciocchi A; Iurlo A; Tieghi A; Patriarca A; Abruzzese E; Tomassetti S; Marchetti M; Vanni D; Luppi M; Pane F; Breccia M; Siragusa S; Elli EM; Ricco A; Fozza C; Corsetti MT; Fava C; Mazzoni C; Fazi P; La Nasa G; Vignetti M; Vannucchi AM; Efficace F;
Selecting ?-thalassemia Patients for Gene Therapy: A Decision-making Algorithm. in HemaSphere / Hemasphere. 2021 Apr 29;5(5):e555. doi: 10.1097/HS9.0000000000000555. eCollection 2021 May.
2021
ASL Asti
ASL Vercelli
AOU San Luigi di Orbassano
Forni GL; Gigante A; Marchetti M; Pinto V; Rigano P; Origa R; Longo F; Graziadei G; De Franceschi L; Casale M; Baronciani D;
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. in Hematological oncology / Hematol Oncol. 2021 Aug;39(3):326-335. doi: 10.1002/hon.2861. Epub 2021 Mar 26.
2021
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
AOU Alessandria
AOU Novara
Cuneo A; Foà R; Marchetti M; Gentile M; Vignetti M; Mauro FR; Crea E; Marasca R; Laurenti L; Molinari AL; Pietrasanta D; Quaglia FM; Sportoletti P; Paolini R; Varettoni M; Gaidano G; Murru R; Vitagliano O; Coscia M; Farina L; Cibien F; Zamprogna G; Arena V; Visentin A; Reda G; Cavazzini F; Piciocchi A; Montillo M; Rigolin GM; et alii...
Selecting ?-Thalassemia Patients for Gene Therapy: A Decision-making Algorithm in HemaSphere
2021
ASL Asti
Baronciani D; Casale M; De Franceschi L; Graziadei G; Longo F; Origa R; Rigano P; Pinto V; Marchetti M; Gigante A; Iolascon A; Forni GL;
2021
ASL Asti
Visentin A; Pravato S; Mauro FR; Pietrasanta D; Fresa A; Vitale C; Ciolli S; Cassin R; Cibien F; Sportoletti P; Gentile M; Rigolin GM; Quaglia FM; Murru R; Gozzetti A; Molica S; Marchetti M; Scarfò L; Guardalben E; Avitabile A; Reda G; Coscia M; Laurenti L; Pizzolo G; Semenzato G; Foà R; Cuneo A; Trentin L;
Selecting ?-Thalassemia Patients for Gene Therapy: A Decision-making Algorithm in HemaSphere
2021
ASL Asti
Baronciani D; Casale M; De Franceschi L; Graziadei G; Longo F; Origa R; Rigano P; Pinto V; Marchetti M; Gigante A; Iolascon A; Forni GL;
Selecting ?-Thalassemia Patients for Gene Therapy: A Decision-making Algorithm in HemaSphere
2021
ASL Asti
Baronciani D; Casale M; De Franceschi L; Graziadei G; Longo F; Origa R; Rigano P; Pinto V; Marchetti M; Gigante A; Iolascon A; Forni GL;
Frontline Siltuximab and Rituximab in TAFRO syndrome: A case report. in European journal of haematology / Eur J Haematol. 2020 Oct;105(4):505-507. doi: 10.1111/ejh.13473. Epub 2020 Jul 16.
2020
ASL Asti
ASL Vercelli
Feyles E; Marchetti M; Zinzani P;
Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study. in Cancer medicine / Cancer Med. 2020 Nov;9(22):8468-8479. doi: 10.1002/cam4.3470. Epub 2020 Sep 24.
2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
AO Cuneo
AOU Novara
Vignetti M; Foà R; Ghia P; Cimino G; Cavallari M; Cucci R; de la Serna J; Ferrarini I; Medina Perez A; Mauro FR; Coscia M; Di Raimondo F; Farina L; Molica S; Gaidano G; Doubek M; Ilariucci F; Tedeschi A; Marchetti M; Spacek M; Trentin L; Billio A; Ujjani CS; Roeker L; Orlandi EM; Schuster SJ; Shah NN; Sehgal AR; Pu JJ; et alii...
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study. in Blood cancer journal / Blood Cancer J. 2020 May 18;10(5):58. doi: 10.1038/s41408-020-0326-1.
2020
ASL Biella
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
AO Cuneo
AOU Alessandria
Sonneveld P; Boccadoro M; Larocca A; Musto P; Romano A; Ria R; Giuliani N; Offidani M; Liberati AM; Marchetti M; Mosca-Siez ML; de Fabritiis P; Ballanti S; Monaco F; Gobbi M; Cellini C; Grasso M; Ronconi S; Pescosta N; Petrucci MT; Capra A; Zambello R; Mina R; Di Lullo G; Belotti A;
Second cancers in MPN: Survival analysis from an international study. in American journal of hematology / Am J Hematol. 2020 Mar;95(3):295-301. doi: 10.1002/ajh.25700. Epub 2019 Dec 22.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
Barbui T; Rambaldi A; Alvarez-Larran A; Vannucchi AM; Griesshammer M; Pane F; De Stefano V; Tieghi A; Isfort S; Recasens V; McMullin MF; Cacciola R; Carli G; Benevolo G; Angona A; Fox ML; Beggiato E; Lunghi F; Wille K; Perez-Encinas M; Rapezzi D; Erez D; Gomez M; Palova M; Casetti IC; Stephenson C; Elli EM; Guglielmelli P; Rumi E; et alii...
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study. in HemaSphere / Hemasphere. 2020 Jun 8;4(3):e395. doi: 10.1097/HS9.0000000000000395. eCollection 2020 Jun.
2020
ASL Asti
ASL Vercelli
Trentin L; Semenzato G; Marasca R; Cuneo A; Luppi M; Bassan R; Krampera M; Marinello S; Piazza F; Gherlinzoni F; Riva M; Briani C; Cibien F; Rigolin GM; Paolini R; Sancetta R; Ferrarini I; Marchetti M; Nasillo V; Visentin A;
Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara
Di Veroli A; Vannucchi AM; Barbui T; Rambaldi A; Griesshammer M; Alvarez-Larran A; Isfort S; Marchetti M; McMullin MF; Tieghi A; Recasens V; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Lunghi F; Angona A; Wille K; Perez-Encinas M; Erez D; Gomez M; Rapezzi D; Palova M; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; et alii...
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report. in Blood / Blood. 2020 Aug 6;136(6):763-766. doi: 10.1182/blood.2020006854.
2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
Foà R; Marasca R; Laurenti L; Trentin L; Mauro FR; Gattei V; Ibatici A; Rigolin GM; Orsucci L; Pietrasanta D; Re F; Marchetti M; De Paoli L; Varettoni M; Quaglia FM; Reda G; Scarfò L; Cuneo A;
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia. in Haematologica / Haematologica. 2020 Apr;105(4):1042-1054. doi: 10.3324/haematol.2019.217430. Epub 2019 Jul 9.
2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara
Boccadoro M; Gattei V; Foà R; Massaia M; Gaidano G; Zenz T; Bernardi R; Mauro FR; Laurenti L; Del Poeta G; Kodipad AA; Omedè P; Magliulo D; Rossi D; Marchetti M; Bonello L; Pozzato G; Bo MD; Kopecka J; Bomben R; Salvetti C; Riganti C; Todaro M; Vitale C; Griggio V; Coscia M;
Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. in Leukemia / Leukemia. 2020 Apr;34(4):1208-1209. doi: 10.1038/s41375-019-0616-4. Epub 2019 Nov 7.
2020
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
De Stefano V; Marchetti M; Vannucchi AM; Ghirardi A; Barbui T;
2020
ASL Asti
Del Giudice I; Rigolin GM; Bardi A; Melandri A; Cavallari M; Raponi S; Ilari C; Cafforio L; Piciocchi A; Arena V; Fabri S; Albano F; Nanni M; Molica S; Reda G; Sportoletti M; Trentin L; Marchetti M; Peragine N; Mariglia P; Vignetti M; Mauro FR; Guarini A; Foà R; Cuneo A;
2020
ASL Asti
AOU Città della Salute di Torino
Cavallo F; Arcaini L; Boccadoro M; Garcia Sanz R; Varettoni M; Marcheselli L; Gilestro M; Picone C; Dogliotti I; Defrancesco I; Ferrari A; Merli M; Zamprogna G; Laurenti L; Tomassetti S; Cencini E; Loseto G; Marino D; Marchetti M; Re F; Sica A; Olivieri J; Puig N; Rattotti S; Zibellini S; Candido C; Drandi D; Ferrero S; Ferrante M; et alii...
Worldwide Examination of Patients with CLL Hospitalized for COVID-19 in Blood
2020
ASL Asti
AOU Città della Salute di Torino
Roeker LE; Scarfo L; Chatzikonstantinou T; Abrisqueta P; Eyre TA; Cordoba R; Muntañola Prat A; Villacampa G; Leslie LA; Koropsak M; Quaresmini G; Allan JN; Furman RR; Bhavsar EB; Pagel JM; Hernandez-Rivas JA; Patel K; Motta M; Bailey N; Miras F; Lamanna N; Alonso R; Osorio-Prendes S; Vitale C; Kamdar M; Baltasar P; Österborg A; Hanson L; Baile M; et alii...
2020
ASL Asti
AOU Città della Salute di Torino
Visentin A; Mauro FR; Pietrasanta D; Fresa A; Vitale C; Ciolli S; Cassin R; Cibien F; Sportoletti P; Gentile M; Rigolin GM; Quaglia FM; Murru R; Gozzetti A; Molica S; Marchetti M; Scarfo L; Reda G; Coscia M; Laurenti L; Pizzolo G; Semenzato G; Foà R; Cuneo A; Trentin L;
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia in Haematologica
2020
ASL Asti
Griggio V; Vitale C; Todaro M; Riganti C; Kopecka J; Salvetti C; Bomben R; Bo MD; Magliulo D; Rossi D; Pozzato G; Bonello L; Marchetti M; Omedè P; Kodipad AA; Laurenti L; Poeta GD; Mauro FR; Bernardi R; Zenz T; Gattei V; Gaidano G; Foà R; Massaia M; Boccadoro M; Coscia M;
HIF-1? is over-expressed in leukemic cells from TP53-disrupted patients and is a promising therapeutic target in chronic lymphocytic leukemia in Haematologica
2020
ASL Asti
Griggio V; Vitale C; Todaro M; Riganti C; Kopecka J; Salvetti C; Bomben R; Bo MD; Magliulo D; Rossi D; Pozzato G; Bonello L; Marchetti M; Omedè P; Kodipad AA; Laurenti L; Poeta GD; Mauro FR; Bernardi R; Zenz T; Gattei V; Gaidano G; Foà R; Massaia M; Boccadoro M; Coscia M;
Infection control in patients treated for chronic lymphocytic leukemia with ibrutinib or idelalisib: recommendations from Italian society of hematology. in Leukemia research / Leuk Res. 2019 Jun;81:88-94. doi: 10.1016/j.leukres.2019.04.016. Epub 2019 May 2.
2019
ASL Asti
ASL Vercelli
Tura S; Pane F; Marchetti M; Girmenia C; Gaidano G; Zinzani PL; Rambaldi A; Barosi G;
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. in Leukemia / Leukemia. 2019 Aug;33(8):1996-2005. doi: 10.1038/s41375-019-0487-8. Epub 2019 May 29.
2019
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
Vannucchi AM; Alvarez-Larran A; Griesshammer M; Recasens V; Marchetti M; Tieghi A; McMullin MF; Cacciola R; Carli G; Benevolo G; Fox ML; Beggiato E; Perez-Encinas M; Lunghi F; Angona A; Wille K; Gomez M; Bertolotti L; Erez D; Palova M; Elli EM; Guglielmelli P; Casetti IC; Stephenson C; Patriarca A; Rumi E; Scaffidi L; Bonifacio M; Delaini F; et alii...
2019
ASL Asti
AOU Città della Salute di Torino
Vitale C; Salvetti C; Griggio V; Scamuffa MC; Zamprogna G; Visentin A; Cassin R; Laurenti L; Murru R; Rivela P; Marchetti M; Gentile M; Pennese E; Reda G; Trentin L; Tedeschi A; Mauro FR; Foà R; Boccadoro M; Coscia M;
Frequency of Thrombosis Is Higher in MPN Patients Who Develop Second Cancer Than in Controls in Blood
2019
ASL Asti
AOU Città della Salute di Torino
De Stefano V; Ghirardi A; Masciulli A; Carobbio A; Palandri F; Vianelli N; Rossi E; Betti S; Di Veroli A; Iurlo A; Cattaneo D; Finazzi G; Bonifacio M; Scaffidi L; Patriarca A; Rumi E; Casetti IC; Stephenson C; Guglielmelli P; Elli EM; Palova M; Rapezzi D; Erez D; Gomez M; Wille K; Pérez-Encinas M; Lunghi F; Angona A; Fox ML; et alii...
Clinical characteristics and outcome of west nile virus infection in patients with lymphoproliferative diseases: A multicenter study in Haematologica
2019
ASL Asti
Visentin A; Nasillo V; Marchetti M; Ferrarini I; Paolini R; Sancetta R; Rigolin GM; Cibien F; Imbergamo S; Riva M; Briani C; Marinello S; Piazza F; Gherlinzoni F; Krampera M; Bassan R; Cuneo A; Marasca R; Semenzato G; Trentin L;
2019
ASL Asti
AO Ordine Mauriziano
Mauro FR; Molica S; Paoloni F; Reda G; Trentin L; Marchetti M; Pietrasanta D; Coscia M; Marasca R; Sportoletti P; Gaidano G; Orsucci L; Stelitano C; Di Renzo N; Liberati M; Gottardi D; Re F; Ilariucci F; Zinzani PL; Mannina D; Gozzetti A; Molinari AL; Gentile M; Chiarenza A; Laurenti L; Varettoni M; Ibatici A; Murru R; Tani M; et alii...
2019
AO Ordine Mauriziano
ASL Asti
Mauro FR; Molica S; Paoloni F; Reda G; Trentin L; Marchetti M; Pietrasanta D; Coscia M; Marasca R; Sportoletti P; Gaidano G; Orsucci L; Stelitano C; Di Renzo N; Liberati AM; Gottardi D; Re F; Ilariucci F; Zinzani P; Mannina D; Gozzetti A; Molinari AL; Gentile M; Consoli U; Laurenti L; Arcaini L; Ibatici A; Murru R; Tani M; et alii...
Selecting ß-Thalassemia Patients for Gene Therapy: A Decision-Making Algorithm in Blood
2019
ASL Asti
Baronciani D; Casale M; De Franceschi L; Graziadei G; Longo F; Origa R; Pinto VM; Rigano P; Marchetti M; Gigante A; Angelucci E; Cappellini MD; Iolascon A; Piga A; Forni GL;
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib. in British journal of haematology / Br J Haematol. 2018 Sep;182(5):701-704. doi: 10.1111/bjh.15450. Epub 2018 Jul 9.
2018
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara
Boccadoro M; Mezzabotta M; Marchetti M; Lanzarone G; Cerrano M; Frairia C; Beggiato E; Pugliese N; Elli EM; Martinelli V; Palumbo GA; Cilloni D; Ferrero D; Crisà E;
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet. in Leukemia / Leukemia. 2018 May;32(5):1057-1069. doi: 10.1038/s41375-018-0077-1. Epub 2018 Feb 27.
2018
ASL Asti
ASL Vercelli
Kroeger N; Finazzi G; Bacigalupo A; Marchetti M; Koschmieder S; Hasselbalch HC; Harrison C; Mc Mullin MF; Cervantes F; Reiter A; Hehlmann R; Kiladjian JJ; Mesa R; Verstovsek S; Hoffman R; Silver RT; Passamonti F; Vannucchi AM; Tefferi A; Barbui T; Griesshammer M; Birgegard G; Barosi G;
Lymphoproliferative disorders in patients with chronic myeloproliferative neoplasms: A systematic review. in American journal of hematology / Am J Hematol. 2018 May;93(5):698-703. doi: 10.1002/ajh.25049. Epub 2018 Feb 10.
2018
ASL Asti
ASL Vercelli
Barbui T; Capitoni E; Carobbio A; Marchetti M;
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study. in Haematologica / Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.
2018
ASL Asti
AOU Città della Salute di Torino
ASL Vercelli
Eyre TA; Kennedy B; Schuh A; Smolej L; Montillo M; Cortelezzi A; Ciolli S; Forconi F; Gonzalez M; Re F; Gaidano G; Molica S; Marchetti M; Ilariucci F; Meneghini V; Chiarenza A; Marasca R; Amendola A; Billio A; Visco C; Mauro FR; Galieni P; Orlandi EM; Farina L; Delgado AR; Musuraca G; Laurenti L; Coscia M; Perez AM; et alii...
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study. in Blood / Blood. 2018 Aug 2;132(5):547-550. doi: 10.1182/blood-2018-03-835413. Epub 2018 Jun 13.
2018
ASL Asti
ASL Vercelli
Fazi P; Marchetti M; Salvi F; Mauro FR; Lucchini E; Farina M; D'Adda M; Binda F; Fattizzo B; Paoloni F; Gramegna D; Rossi G; Zaja F; Barcellini W;
Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2017 Oct;17(5):469-480. doi: 10.1080/14737167.2017.1366858. Ep
2017
ASL Asti
ASL Vercelli
Marchetti M;
Identification of new BMP6 pro-peptide mutations in patients with iron overload. in American journal of hematology / Am J Hematol. 2017 Jun;92(6):562-568. doi: 10.1002/ajh.24730. Epub 2017 Apr 29.
2017
ASL Asti
AOU San Luigi di Orbassano
ASL Città di Torino
ASL Vercelli
Girelli D; Delledonne M; Olivieri O; Giorgetti A; Suku E; Xumerle L; Roetto A; Marchetti M; De Gobbi M; Badar S; Busti F; Rizzi M; Marchi G; Castagna A; Piubelli C;
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations. in Leukemia / Leukemia. 2017 Apr;31(4):882-888. doi: 10.1038/leu.2016.283. Epub 2016 Oct 14.
2017
ASL Asti
ASL Vercelli
Passamonti F; McMullin MF; Kröger N; Kiladjian JJ; Hehlmann R; Harrison C; Griesshammer M; Birgegård G; Cervantes F; Barosi G; Marchetti M; Vannucchi A; Barbui T;
2017
ASL Asti
Ghia P; Foa R; Follows GA; De La Serna J; Vignetti M; Gaidano G; Ilariucci F; Meneghini V; Chiarenza A; González M; Re F; Marchetti M; Marasca R; Pizzuti M; Visco C; Ciolli S; Orlandi EM; Rivas-Delgado A; Farina L; Musuraca G; Coscia M; Perez AM; Trentin L; Gentile M; Montillo M; Molica S; Mauro FR; Laurenti L; Galieni P; et alii...
2017
ASL Asti
Rossi G; Paoloni F; Fattizzo B; Binda F; D'Adda M; Farina M; Carbone C; Zaja F; Lucchini E; Mauro FR; Salvi F; Marchetti M; Fazi P; Barcellini W;
The expert in haemostasis and thrombosis: Is an economic analysis feasible? in Value in Health
2017
ASL Asti
Rognoni C; Liberato L; Marchetti M; Testa S; Quaglini S;
Erythropoiesis stimulating agents can improve anemia in patients with myelofibrosis treated with ruxolitinib in Haematologica
2017
ASL Asti
AO Ordine Mauriziano
Crisà E; Daniela C; Elli EM; Beggiato E; Frairia C; Cerrano M; Lanzarone G; Marchetti M; Mezzabotta M; Boccadoro M; Ferrero D;
Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for stroke prevention in non-valvular atrial fibrillation: a systematic and qualitative review. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2016;16(2):221-35. doi: 10.1586/14737167.2016.1147351. Epub 20
2016
ASL Asti
ASL Vercelli
Marchetti M; Liberato NL;
Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation guidelines for the management of indolent, nonfollicular B-cell lymphoma (marginal zone, lymphoplasmacytic, and small lymphocytic lymphoma). in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2015 Feb;15(2):75-85. doi: 10.1016/j.clml.2014.07.002. Epub 2014 Jul 15.
2015
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino
ASL Vercelli
Vitolo U; Rambaldi A; Marchetti M; Billio A; Barosi G; Baldini L; Arcaini L; Tarella C; Zinzani PL; Tura S;
2015
AO Ordine Mauriziano
ASL Asti
Griggio V; Vitale C; Riganti C; Kopecka J; Dal Bo M; Rossi D; Pozzato G; Laurenti L; Zallio F; Marchetti M; Ruggeri M; Omedè P; Del Poeta G; Gattei V; Gaidano G; Boccadoro M; Massaia M; Coscia M;
2015
ASL Asti
Marchetti M; Cuneo A; Mauro FR; Montillo M; Martelli E; Pedone MP;
Appropriate use of bendamustine in first-line therapy of chronic lymphocytic leukemia. Recommendations from SIE, SIES, GITMO Group. in Leukemia research / Leuk Res. 2014 Nov;38(11):1269-77. doi: 10.1016/j.leukres.2014.06.017. Epub 2014 Jul 7.
2014
ASL Asti
Cuneo A; Marchetti M; Barosi G; Billio A; Brugiatelli M; Ciolli S; Laurenti L; Mauro FR; Molica S; Montillo M; Zinzani P; Tura S;
Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey. in Cytotherapy / Cytotherapy. 2014 Jan;16(1):101-10. doi: 10.1016/j.jcyt.2013.07.001. Epub 2013 Oct 26.
2014
ASL Asti
ASL Vercelli
Gotti E; Dal Pozzo S; Marchetti M; Mancini S; Pandolfi A; Risso M; Perseghin P; Bosi A; Accorsi P; Introna M; Pierelli L; Olivieri J; Rambaldi A; Leoni P; Olivieri A;
Biological therapies in Crohn's disease: are they cost-effective? A critical appraisal of model-based analyses. in Expert review of pharmacoeconomics & outcomes research / Expert Rev Pharmacoecon Outcomes Res. 2014 Dec;14(6):815-24. doi: 10.1586/14737167.2014.957682. Epub
2014
ASL Asti
ASL Vercelli
Marchetti M; Liberato NL;
SIE-SIES-GITMO guidelines for the management of adult peripheral T- and NK-cell lymphomas, excluding mature T-cell leukaemias. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2014 Dec;25(12):2339-2350. doi: 10.1093/annonc/mdu152. Epub 2014 Apr 9.
2014
AO Cuneo
ASL Asti
Pimpinelli N; Pileri S; Gallamini A; Billio A; Barosi G; Marchetti M; Corradini P; Rossi G; Zinzani PL; Tura S;
2014
ASL Asti
Marchetti M; Barosi G; Pedrazzoli P;
Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis in Journal of Thrombosis and Thrombolysis
2014
ASL Asti
Rognoni C; Marchetti M; Quaglini S; Liberato NL;
Apixaban, dabigatran, and rivaroxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: A cost-effectiveness analysis in Clinical Drug Investigation
2014
ASL Asti
Rognoni C; Marchetti M; Quaglini S; Liberato NL;
Cost-effectiveness of edoxaban, apixaban, rivaroxaban and dabigatran versus warfarin for stroke prevention in nonvalvular atrial fibrillation in Haematologica
2014
ASL Asti
Marchetti M; Liberato NL; Rognoni C; Quaglini S;
2014
ASL Asti
Marchetti M; Barosi G;
Extracorporeal photopheresis for the treatment of acute and chronic graft-versus-host disease in adults and children: best practice recommendations from an Italian Society of Hemapheresis and Cell Manipulation (SIdEM) and Italian Group for Bone Marrow Transplantation (GITMO) consensus process. in Transfusion / Transfusion. 2013 Oct;53(10):2340-52. doi: 10.1111/trf.12059. Epub 2013 Jan 10.
2013
ASL Asti
Pierelli L; Perseghin P; Marchetti M; Messina C; Perotti C; Mazzoni A; Bacigalupo A; Locatelli F; Carlier P; Bosi A;
Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn's disease. in The European journal of health economics : HEPAC : health economics in prevention and care / Eur J Health Econ. 2013 Dec;14(6):853-61. doi: 10.1007/s10198-012-0430-7. Epub 2012 Sep 14.
2013
ASL Asti
ASL Vercelli
Liberato NL; Marchetti M; Di Sabatino A; Corazza GR;
SIE, SIES, GITMO revised guidelines for the management of follicular lymphoma in American Journal of Hematology
2013
ASL Asti
Zinzani PL; Marchetti M; Billio A; Barosi G; Carella AM; Lazzarino M; Martelli M; Rambaldi A; Rigacci L; Tarella C; Vitolo U; Tura S;
Cancer-related fatigue in Italian cancer patients: Validation of the Italian version of the Brief Fatigue Inventory (BFI) in Supportive Care in Cancer
2013
ASL Asti
Catania G; Bell C; Ottonelli S; Marchetti M; Bryce J; Grossi A; Costantini M;
Implantable cardioverter defibrillator (ICD) and sudden cardiac death (SCD) prevention: Results from a medium-term follow-up in Giornale Italiano di Cardiologia
2012
ASL Biella
ASL Asti
ASL Torino 3
ASL Torino 4
ASL Città di Torino
Gaita F; Pozzi R; Riccardi R; Scaglione M; Marra S; Marcolongo M; Mangeroni G; Budano C; Golzio P; Bernardi A; Barbero U; Iannaccone M; Marchetti M; Antolini M; Bissolino A; Alessandro F; Amoroso G;
Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: An analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo in Bone Marrow Transplantation
2012
ASL Asti
AO Ordine Mauriziano
Olivieri A; Marchetti M; Lemoli R; Tarella C; Iacone A; Lanza F; Rambaldi A; Bosi A;
Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: A cost-utility analysis in Annals of Oncology
2012
ASL Asti
Liberato NL; Rognoni C; Rubrichi S; Quaglini S; Marchetti M; Gorlia T; Licitra L; Vermorken JB;
Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment. in Infection / Infection. 2011 Aug;39(4):375-8. doi: 10.1007/s15010-011-0109-5. Epub 2011 May 3.
2011
ASL Asti
ASL Vercelli
Marchetti M; Zallio F; Casabianca A; Feyles E; Concialdi E; Ferroglio E; Biglino A;
2011
ASL Asti
Gallamini A; Marchetti M; Borra A; Sorasio R; Fiore F;